Ernexa Therapeutics Inc. (ERNA) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2010: $3.66M2011: $5.30M2012: $4.76M2013: $6.25M2014: $11.34M2015: $12.56M2016: $12.63M2017: $11.03M2018: $7.95M2019: $9.03M2020: $5.25M2021: $6.02M2022: $10.17M2023: $46.90M2024: $3.57M2025: $3.43M$3.43M
2010Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$3.43M-3.8%
2024$3.57M-92.4%
2023$46.90M+361.1%
2022$10.17M+68.9%
2021$6.02M+14.8%
2020$5.25M-41.9%
2019$9.03M+13.7%
2018$7.95M-28.0%
2017$11.03M-12.6%
2016$12.63M+0.5%
2015$12.56M+10.7%
2014$11.34M+81.4%
2013$6.25M+31.4%
2012$4.76M-10.1%
2011$5.30M+44.6%
2010$3.66M